Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 8-K, filed Oct 19, 2026
- Incorporated
- Delaware
- Filings on record
- 33 filings
- On EDGAR
- CIK 2143850
- Fiscal year ends
- December
- Filer status
- Emerging growth company
News 1
Prospectuses and Registrations 4
Ownership 8 of 22
- SCHEDULE 13G Large holder reported a passive stake Nov 6, 2026
- SCHEDULE 13D Large holder reported an active stake Oct 26, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 26, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 22, 2026
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 19, 2026
- 4 Insider reported a trade Oct 19, 2026
Other 6
- EFFECT Notice that a registration became effective Oct 15, 2026
- S-1MEF Oct 15, 2026
- CERT Exchange certified a listing Oct 15, 2026
- 8-A12B Registration of a security for exchange listing Oct 13, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Aug 24, 2026
- DRS Draft registration statement, submitted confidentially Jul 15, 2026
Everything here comes from City Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.